Sonoma Pharmaceuticals In... (SNOA)
NASDAQ: SNOA
· Real-Time Price · USD
5.32
0.05 (0.95%)
At close: Aug 15, 2025, 3:59 PM
5.20
-2.26%
After-hours: Aug 15, 2025, 07:58 PM EDT
Sonoma Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Revenue | 14.91M | 14.29M | 13.97M | 13.55M | 12.7M | 12.73M | 12.31M | 12.12M | 12.72M | 13.27M | 12.56M | 12.51M | 12.93M | 12.63M | 12.49M | 14.52M | 16.55M | 20.12M | 22.54M | 22.28M | 21.48M |
Cost of Revenue | 9.29M | 8.82M | 8.95M | 8.33M | 7.85M | 7.99M | 7.79M | 8.23M | 8.48M | 8.79M | 8.85M | 8.43M | 8.94M | 8.63M | 8.78M | 10.03M | 10.79M | 12.85M | 13.56M | 13.14M | 12.55M |
Gross Profit | 5.62M | 5.46M | 5.03M | 5.22M | 4.85M | 4.75M | 4.52M | 3.89M | 4.24M | 4.48M | 3.71M | 4.08M | 3.99M | 3.99M | 3.7M | 4.5M | 5.76M | 7.27M | 8.97M | 9.14M | 8.93M |
Operating Income | -3.63M | -3.71M | -4.46M | -4.28M | -4.63M | -4.7M | -4.44M | -5.43M | -4.95M | -4.57M | -6.48M | -5.6M | -5.84M | -5.89M | -5.64M | -4.82M | -3.69M | -2.67M | -2.61M | -3.45M | -4.82M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | 12K | 13K | 16K | 16K | 4K | 3K | n/a | n/a | 2K | 5K | 13K | 15K | 13K | 43K | 77K |
Pretax Income | -3.15M | -2.91M | -3.74M | -3.74M | -4.58M | -5.03M | -5.11M | -6.09M | -5.71M | -5.18M | -7.03M | -6.07M | -5.24M | -5.42M | -4.86M | -4.54M | -4.29M | -3.15M | -1.69M | -2.15M | -3.5M |
Net Income | -3.56M | -3.46M | -3.75M | -3.69M | -4.56M | -4.83M | -5.08M | -6.15M | -5.68M | -5.15M | -6.79M | -5.79M | -4.88M | -5.09M | -5.8M | -5.51M | -5.29M | -3.2M | -911K | -1.34M | -2.67M |
Selling & General & Admin | 7.32M | 7.36M | 7.68M | 7.51M | 7.46M | 7.58M | 7.29M | 8.26M | 8.66M | 8.84M | 10.18M | 9.65M | 9.78M | 9.76M | 9.09M | 9.06M | 9.28M | 9.38M | 10.68M | 11.47M | 12.28M |
Research & Development | 1.94M | 1.81M | 1.81M | 1.99M | 2.02M | 1.87M | 1.66M | 1.46M | 1.13M | 807K | 610K | 236K | 46K | 124K | 250K | 257K | 162K | 554K | 907K | 1.12M | 1.48M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -73K | -262K | -262K | -262K | -178K | 11K | 11K | 11K | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 9.26M | 9.18M | 9.49M | 9.49M | 9.48M | 9.45M | 8.96M | 9.32M | 9.19M | 9.04M | 10.19M | 9.69M | 9.82M | 9.88M | 9.34M | 9.31M | 9.44M | 9.93M | 11.58M | 12.59M | 13.75M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | 292K | 293K | 296K | 296K | 13K | 15K | 16K | 17K | 8K | 10K | 10K | 11K | 81K | 77K | 75K |
Selling & Marketing Expenses | n/a | n/a | 156K | 156K | 156K | 156K | 156K | 156K | 156K | 156K | 86K | 86K | 86K | 86K | 41K | 41K | 41K | 41K | n/a | n/a | n/a |
Cost & Expenses | 18.54M | 18M | 18.44M | 17.82M | 17.33M | 17.44M | 16.75M | 17.55M | 17.67M | 17.84M | 19.04M | 18.12M | 18.76M | 18.51M | 18.13M | 19.34M | 20.23M | 22.78M | 25.15M | 25.73M | 26.3M |
Income Tax Expense | 403K | 550K | 10K | -56K | -17K | -196K | -35K | 56K | -30K | -32K | -239K | -270K | -365K | -329K | 1.04M | 1.04M | 1.03M | -74K | -510K | -643K | -682K |
Shares Outstanding (Basic) | 1.64M | 1.24M | 1.46M | 1.03M | 851.45K | 780.37K | 545.45K | 516.4K | 493.6K | 467.81K | 310.7K | 310.1K | 310.1K | 277.04K | 308K | 234.4K | 209.3K | 208.5K | 205.2K | 200.8K | 183.9K |
Shares Outstanding (Diluted) | 1.64M | 1.24M | 1.46M | 1.03M | 851.45K | 780.37K | 545.45K | 516.4K | 493.6K | 467.81K | 310.7K | 310.1K | 310.1K | 277.04K | 308K | 234.4K | 209.3K | 208.5K | 205.2K | 215.9K | 184.3K |
EPS (Basic) | -2.61 | -3.19 | -3.93 | -4.89 | -7.17 | -8.7 | -10.13 | -14.78 | -15.19 | -15.18 | -23.01 | -19.83 | -16.98 | -19.36 | -26.29 | -26.27 | -25.25 | -23.02 | -13.2 | -17.38 | -27.11 |
EPS (Diluted) | -2.61 | -3.19 | -3.93 | -4.89 | -7.17 | -8.7 | -10.13 | -14.78 | -15.19 | -15.18 | -23.01 | -19.83 | -16.98 | -19.36 | -26.29 | -26.27 | -25.29 | -23.06 | -13.24 | -17.42 | -27.11 |
EBITDA | -3.53M | -3.57M | -4.32M | -4.12M | -4.46M | -4.53M | -4.27M | -5.27M | -4.81M | -4.44M | -6.34M | -5.46M | -5.67M | -5.7M | -5.37M | -4.5M | -3.37M | -3.13M | -1.6M | -2.55M | -4M |
EBIT | -3.78M | -3.71M | -4.46M | -4.28M | -4.63M | -4.7M | -4.44M | -5.43M | -4.95M | -4.57M | -6.48M | -5.6M | -5.84M | -5.89M | -5.54M | -4.72M | -3.59M | -3.35M | -1.88M | -2.83M | -4.2M |
Depreciation & Amortization | 135K | 138K | 148K | 160K | 170K | 176K | 342K | 329K | 312K | 298K | 363K | 368K | 392K | 409K | 177K | 220K | 222K | 227K | 287K | 275K | 289K |